Alpine Immune Sciences Inc reports results for the quarter ended in September - Earnings Summary

Alpine Immune Sciences

14/11/2022 22:03

* Alpine Immune Sciences Inc  ALPN.OQ  reported a quarterly
adjusted loss of 42 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 10 cents per share.
    * Revenue fell 1.7% to $8.37 million from a year ago;
analysts
expected $18.69 million. 
    * Alpine Immune Sciences Inc's reported EPS for the quarter
was a
loss of 42 cents​.
    * The mean earnings estimate of analysts had risen by
about 18% in
the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Alpine Immune Sciences Inc shares had fallen by 19.9% this
quarter and lost 58.3% so far this year.
    * The company reported a quarterly loss of $13.27 million.
    * Wall Street's median 12-month price target for Alpine
Immune
Sciences Inc is $14.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.10          -0.42          Missed
 Jun. 30 2022      -0.39          -0.60          Missed
 Mar. 31 2022      -0.19          -0.25          Missed
 Dec. 31 2021      -0.30          -0.52          Missed